IpilimumabAlopecia universalis, vitiligo, hypophysitis, ileitis and colitis: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2013年 / 1451卷 / 1期

关键词：

D O I：

10.1007/s40278-013-2989-x

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：30 / 30

相关论文

共 50 条

[31] IpilimumabFirst report of hypophysitis: 3 case reports
Reactions Weekly, 2010, 1283 (1) : 59 - 59
[32] TicilimumabFirst reports of hypopituitarism and hypophysitis: case report
Reactions Weekly, 2007, 1158 (1) : 25 - 26
[33] AntineoplasticsFatigue, hypophysitis and rash: 3 case reports
Reactions Weekly, 2023, 1965 (1) : 43 - 43
[34] ImmunotherapiesAseptic meningoencephalitis and hypophysitis: 5 case reports
Reactions Weekly, 2021, 1872 (1) : 256 - 256
[35] Case of vitiligo universalis as a sequela of drug-induced hypersensitivity syndrome
Chiang, Pin-Hsuan
Ng, Chau Yee
Kuo, Tseng-Tong
Hui, Rosaline Chung-Yee
Chen, Chun-Bing
Lu, Chun-Wei
Chung, Wen-Hung
JOURNAL OF DERMATOLOGY, 2021, 48 (01): : 92 - 95
[36] Update: Autoimmune side effects of ipiliumumab and pembrolizumab in metastatic melanoma. Case study of patient with hypophysitis, pneumonitis, colitis, vitiligo
Harris, V.
Guminski, A.
Smith, S. D.
AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2017, 58 : 60 - 60
[37] Alemtuzumab/cladribineAutoimmune thyroid disorder and alopecia areata universalis: 2 case reports
Reactions Weekly, 2022, 1898 (1) : 29 - 29
[38] Ipilimumab/nivolumab/pembrolizumabSkin rash and vitiligo: 2 case reports
Reactions Weekly, 2019, 1776 (1) : 248 - 248
[39] ImiquimodGenital vitiligo-like hypopigmentation: 2 case reports
Reactions Weekly, 2018, 1700 (1) : 139 - 139
[40] Ipilimumab/nivolumabHepatitis and colitis: 2 case reports
Reactions Weekly, 2020, 1829 (1) : 223 - 223

← 1 2 3 4 5 →